Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and tuberculosis: the double whammy of respiratory pathogens
Mohd Shariq, Javaid Ahmad Sheikh, Neha Quadir, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210264-210264
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Tuberculosis: past and present
Igor Ivanes, Aurelia Ustian, Constantin Iavorschi
Bulletin of the Academy of Sciences of Moldova Medical Sciences (2024) Vol. 77, Iss. 3, pp. 234-238
Open Access | Times Cited: 77
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
Martin Achleitner, Charlotte Steenblock, Juliane Dänhardt, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2872-2877
Open Access | Times Cited: 26
Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
Kona Chowdhury, Rahnuma Ahmad, Susmita Sinha, et al.
Cureus (2023)
Open Access | Times Cited: 20
Neuroimmune recognition and regulation in the respiratory system
Jie Chen, Xiaoyun Lai, Yuanlin Song, et al.
European Respiratory Review (2024) Vol. 33, Iss. 172, pp. 240008-240008
Open Access | Times Cited: 6
Diagnostic value of third-generation nanopore sequencing in extrapulmonary tuberculosis
Chang Seob Song, Chunyan Zhao, Yanrong Lin, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
Jianhui Yang, Esben Strodl, Dandan Zhang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Characterization and anti-tuberculosis effects of γδ T cells expanded and activated by Mycobacterium tuberculosis heat-resistant antigen
Fangzheng Guo, Yamin Song, Shuyun Dong, et al.
Virulence (2025) Vol. 16, Iss. 1
Open Access
Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in understanding TB and cancer
Asrar Ahmad Malik, Javaid Ahmad Sheikh, Nasreen Z. Ehtesham, et al.
International Journal of Medical Microbiology (2022) Vol. 312, Iss. 5, pp. 151558-151558
Open Access | Times Cited: 23
Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring
Nguyen Ky Anh, Nguyen Ky Phat, Nguyen Thi Hai Yen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114187-114187
Open Access | Times Cited: 13
Two Difficult Pandemics: Tuberculosis and COVID-19
Zeynep Yeğin Katran, Aylin Babalık, Ayla Türkar, et al.
International Journal of Mycobacteriology (2024) Vol. 13, Iss. 1, pp. 28-33
Open Access | Times Cited: 4
Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations
Quan Wang, Yanmin Cao, Xinyu Liu, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 5, pp. e0012136-e0012136
Open Access | Times Cited: 4
Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives
Violina T. Angelova, Tania Pencheva, Nikolay Vassilev, et al.
Antibiotics (2022) Vol. 11, Iss. 5, pp. 562-562
Open Access | Times Cited: 19
Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs
Juan M. Cubillos-Angulo, Betânia M. F. Nogueira, María B. Arriaga, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19
Regulation of autophagy by SARS‐CoV‐2: The multifunctional contributions of ORF3a
Mohd Shariq, Asrar Ahmad Malik, Javaid Ahmad Sheikh, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 9
Learning from COVID-19 to tackle TB pandemic: From despair to hope
Javaid Ahmad Sheikh, Asrar Ahmad Malik, Neha Quadir, et al.
The Lancet Regional Health - Southeast Asia (2022) Vol. 2, pp. 100015-100015
Open Access | Times Cited: 14
Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
Kim R Chiok, Neeraj Dhar, Arinjay Banerjee
iScience (2023) Vol. 26, Iss. 5, pp. 106629-106629
Open Access | Times Cited: 8
Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China
Lei Li, Jianxiang Zhang, Ranran Sun, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The Impact of COVID-19 on the Tuberculosis Features in a Romanian Pneumology Hospital
George-Cosmin Popovici, Costinela-Valerica Georgescu, Claudiu Ionuț Vasile, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 2489-2498
Open Access | Times Cited: 2
Impact of hyperglycemia on tuberculosis treatment outcomes: a cohort study
Yanqiu Xu, Yang Yang, Wu Xiaoqing, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
End Tuberculosis by 2035: Challenges Ahead
Asrar Ahmad Malik, Sanjeev Sinha, Nasreen Z. Ehtesham, et al.
Future Microbiology (2023) Vol. 18, Iss. 8, pp. 461-464
Closed Access | Times Cited: 7
Tuberculosis and COVID-19 Dually Affect Human Th17 Cell Immune Response
Анна Старшинова, Igor Kudryavtsev, Artem Rubinstein, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2123-2123
Open Access | Times Cited: 7
Post COVID and Apheresis – Where are we Standing?
Charlotte Steenblock, Romy Walther, Sergey Tselmin, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 11, pp. 715-720
Open Access | Times Cited: 11
Polypharmacological repurposing approach identifies approved drugs as potential inhibitors of Mycobacterium tuberculosis
Jasdeep Singh, Neha Quadir, Shubham Vashishtha, et al.
Biochemical Journal (2023) Vol. 480, Iss. 14, pp. 1079-1096
Open Access | Times Cited: 6
Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis
Tasmin Nazim, Vipul Kumar, Faraz Ahmed, et al.
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 1
The Impact of COVID-19 on the Tuberculosis Outcomes in a Pneumology Hospital from South-East Romania
George-Cosmin Popovici, Costinela-Valerica Georgescu, Claudiu Ionuț Vasile, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top